Paola Guglielmelli1,2, Alessandro M Vannucchi3,4. 1. CRIMM-Centro Ricerca E Innovazione Delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi. 2. Department of Experimental and Clinical Medicine, University of Florence, DenoThe Excellence Center, Florence, Italy. 3. CRIMM-Centro Ricerca E Innovazione Delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi. amvannucchi@unifi.it. 4. Department of Experimental and Clinical Medicine, University of Florence, DenoThe Excellence Center, Florence, Italy. amvannucchi@unifi.it.
Authors: B Li; P Zhang; G Feng; Z Xu; T Qin; Y Zhang; Z Sha; D Dong; H Zhang; L Fang; L Pan; N Hu; S Qu; W Cai; G Huang; Z Xiao Journal: Blood Cancer J Date: 2016-12-09 Impact factor: 11.037
Authors: Hans Michael Kvasnicka; Jürgen Thiele; Carlos E Bueso-Ramos; William Sun; Jorge Cortes; Hagop M Kantarjian; Srdan Verstovsek Journal: J Hematol Oncol Date: 2018-03-15 Impact factor: 17.388
Authors: Hossam Hodeib; Dina Abd El Hai; Mohamed A Tawfik; Alzahraa A Allam; Amal Selim; Abdallah Ahmed Elsawy; Amira Youssef Journal: Genes (Basel) Date: 2022-03-10 Impact factor: 4.096